The field of oncology is ever-changing, and oncologists need to be up-to-date about recent studies, and new treatment options available to their patients. LWW's journals for oncologists offer a combination of focused, peer reviewed articles, news and opinion to keep oncologists informed of the latest in their fields.
2. Powerful Information, Powerful Treatment
The field of oncology is changing all the time. New studies and treatment
options bring new hope to doctors, patients and their families. While
treatment options are rarely black and white, the more information
oncologists have, the better they’re able offer treatment and guidance
to their patients.
In this presentation, we’ll look at the medical journals that should be on
every oncologist’s must-read list.
2
3. American Journal of Clinical Oncology
A multidisciplinary journal for cancer surgeons, medical oncologists,
radiation oncologists, pediatric oncologists and gynecologic oncologists,
the American Journal of Clinical Oncology provides information on the
latest research, outcome studies, and cost utility analyses. The journal
also and includes opinion pieces and review articles with a focus on the
combined modality and loco-regional management of cancer.
Original, peer-reviewed articles
Multidisciplinary focus
Coverage of ongoing research
Published bimonthly
3
4. Oncology Times
Oncology Times is an award-winning clinical newspaper focused on
breaking clinical news in the fields of oncology, radiology, surgery,
chemotherapy, and biological and gene therapy. Oncology Times
provides news on issues that affect cancer clinicians, including political,
reimbursement, and practice management news. Sections include:
Abstract Tracker, Journal Scan, Eye on Washington, Advocacy InSight,
FDA InSight, Clinical Notes, New Drug Alert, WebView, Meeting Planner,
Protocol Alert, Chemotherapy Error Alert, Shop Talk, and Book Reviews.
Hard-hitting editorials and
special reports
Published bimonthly
4
5. Current Opinion in Oncology
Current Opinion in Oncology offers expert evaluation on all of the latest
advances in oncology from 17 disciplines, including sarcomas,
transplantation, cancer biology and endocrine tumors. Each issue
concerns itself with different topics and disciplines, and provides
bibliographical information from the most important studies within that
discipline from the last year. No matter your discipline, reading Current
Opinion in Oncology ensures that you won’t miss out on important
studies and the latest opinion in clinical care.
Bibliographical information from
100s of top journals
Annotations detailing the merits
of the most important papers
Published bimonthly
5
6. LWW Oncology
A customized research tool for oncologists, LWW Oncology offers access to
in-depth, unbiased treatment information. LWW Oncology allows
immediate access to renowned cancer resources via a custom search tool
that gets you the information you need, when you need it.
Targeted, multidisciplinary content from 12 internationally renowned
oncology textbooks
— Regular updates from DeVita, Hellman and Rosenberg’s Cancer: Principles &
Practice of Oncology.
The latest, most relevant entries from PubMed
Evidence-based clinical practice guidelines from NCCN
Detailed drug monographs
Disease-specific patient education materials
Printable, presentation-ready pathology images
6
7. Learn More
For the latest information on LWW’s oncology
journals, follow the LWW Oncology Journals
page on Facebook.
7
8. About Lippincott Williams & Wilkins
Lippincott Williams & Wilkins (LWW) is a leading international publisher
of trusted content delivered in innovative ways to practitioners,
professionals and students to learn new skills, stay current on their
practice, and make important decisions to improve patient care and
clinical outcomes. LWW is part of Wolters Kluwer Health, a leading
global provider of information, business intelligence and point-of-care
solutions for the healthcare industry. Wolters Kluwer Health is part
of Wolters Kluwer, a market-leading global information services
company with 2011 annual revenues of €3.4 billion ($4.7 billion).
8